Railey Mayatt

Railey Mayatt

Auto-generated profile, based on publicly available information

Railey Mayatt

Department of Chemistry Mississippi State University Mississippi State MS 39762 USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2024 in Small
Verified
Journal Article
Closed access
RSRadha P. Somarathne
Radha P. Somarathne
DADhanush Amarasekara
Dhanush Amarasekara
CKChathuri S. Kariyawasam
Chathuri S. Kariyawasam
HRHarley A. Robertson
Harley A. Robertson
RMRailey Mayatt
Railey Mayatt
NFNicholas C Fitzkee
Nicholas C Fitzkee

7 July 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
RSRadha P. Somarathne
Radha P. Somarathne
DADhanush Amarasekara
Dhanush Amarasekara
CKChathuri S. Kariyawasam
Chathuri S. Kariyawasam
HRHarley A. Robertson
Harley A. Robertson
RMRailey Mayatt
Railey Mayatt
NFNicholas C Fitzkee
Nicholas C Fitzkee
Understanding the conformation of proteins in the nanoparticle corona has important implications in how organisms respond to nanoparticle-based drugs. These proteins coat the nanoparticle surface, and their properties will influence the nanoparticle’s interaction with cell targets and the immune system. While some coronas are thought to be disordered, two key unanswered questions are the degree of disorder and solvent accessibility. Here, using a comprehensive thermodynamic approach, along with supporting spectroscopic experiments, we develop a model for protein corona disorder in polystyrene nanoparticles of varying size. For two different proteins, we find that binding affinity decreases as nanoparticle size increases. The stoichiometry of binding, along with changes in the hydrodynamic size, support a highly solvated, disordered protein corona anchored at a small number of enthalpically-driven attachment sites. The scaling of the stoichiometry vs. nanoparticle size is consistent disordered polymer dimensions. Moreover, we find that proteins are destabilized less severely in the presence of larger nanoparticles, and this is supported by measurements of hydrophobic exposure, which becomes less pronounced at lower curvatures. Our observations hold for flat polystyrene surfaces, which, when controlled for total surface area, have the lowest hydrophobic exposure of all systems. Our model provides an explanation for previous observations of increased amyloid fibrillation rates in the presence of larger nanoparticles, and it may rationalize how cell receptors can recognize protein disorder in therapeutic nanoparticles. TOC Image:

11 December 2025 in bioRxiv
Verified
Preprint
Open access
TSTanveer Shaikh
Tanveer Shaikh
DADhanush Amarasekara
Dhanush Amarasekara
KHKenneth Hulugalla
Kenneth Hulugalla
VTVeeresh Toragall
Veeresh Toragall
RGRyan J. Garrigues
Ryan J. Garrigues
NFNicholas C Fitzkee
Nicholas C Fitzkee
Nanoparticle delivery to tumors remains inefficient, with current nanomedicines achieving only 0.7% injected dose per gram (ID/g) of tumor tissue due to uncontrolled protein corona formation that redirects nanoparticles away from target sites. We engineered biomimetic protein coronas to control nanoparticle-protein interactions and enhance tumor targeting. Competitive binding studies using NMR spectroscopy revealed that transferrin (Tf) and fibronectin (Fn) outcompete albumin (BSA) and immunoglobulin G (IgG) for 15 nm gold nanoparticle surfaces, establishing a binding hierarchy that enables predictable corona composition. Pre-coating nanoparticles with a four-protein combination (BSA+Tf+Fn+IgG) created coronas that selectively enhanced cancer cell uptake while reducing macrophage recognition in vitro. When administered to tumor-bearing mice, these engineered coronas achieved 13 ppm/g tumor accumulation (equivalent to 4% ID/g) representing 6.5-fold improvement over bare nanoparticles and 2.6-fold improvement over PEGylated formulations. Proteomics analysis of secondary coronas formed in human serum revealed that engineered nanoparticles selectively recruit transport and adhesion proteins while limiting immune recognition signatures. The pre-formed coronas maintained targeting protein retention and reduced complement binding compared to controls. Circular dichroism confirmed minimal protein structural perturbation, preserving receptor-binding functionality for active targeting. The strategy harnesses natural protein adsorption processes to create "smart" biological interfaces that simultaneously evade immune clearance and promote tumor cell recognition through multiple receptor pathways. This approach demonstrates the feasibility of treating the coron as a programmable interface, addressing delivery limitations that have hindered clinical translation of cancer nanomedicines.